Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Biological & Pharmaceutical Bulletin|January 28, 2021
Characterization of an Expanded IL-10-Producing-Suppressive T Cell Population Associated with Immune ToleranceYuya Yoshida, Norihisa Mikami, Yusuke Nakanishi, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|September 2, 2014
[Methods for reducing dacarbazine photodegradation and its accompanying venous pain]Takumi Tsuji, Tatsuya Ohtsubo, Takayo Umeyama, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|December 16, 2015
Therapeutic approach to mite-induced intractable dermatitis using novel immunomodulator FTY720 ointment (fingolimod) in NC/Nga miceTakumi Tsuji, Satoshi Okuno, Ayano Kuroda, et al.
Biological & Pharmaceutical Bulletin|May 22, 2015
Functional Mechanism(s) of the Inhibition of Disease Progression by Combination Treatment with Fingolimod Plus Pathogenic Antigen in a Glucose-6-phosphate Isomerase Peptide-Induced Arthritis Mouse ModelYuya Yoshida, Norihisa Mikami, Yuki Matsushima, et al.
Biological & Pharmaceutical Bulletin|April 2, 2005
A novel immunomodulator, FTY720, prevents development of experimental autoimmune myasthenia gravis in C57BL/6 miceTakeyuki Kohno, Takumi Tsuji, Kaori Hirayama, et al.
Bioorganic & Medicinal Chemistry|March 1, 2006
Preparation of antibodies against a novel immunosuppressant, FTY720, and development of an enzyme immunoassay for FTY720Norimasa Matsumoto, Takeyuki Kohno, Shuji Uchida, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|March 3, 2017
Consideration of Preventing Local Venous Pain by DacarbazineTatsuya Ohtsubo, Takumi Tsuji, Takayo Umeyama, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|November 5, 2014
[A self-improvement and participatory career development education program involving internships and volunteer training experience for pharmacy students: results verified in a follow-up survey three years after participation]Wasako Kurio, Motomi Konishi, Tomofumi Okuno, et al.
Biological & Pharmaceutical Bulletin|May 25, 2022
Therapeutic Strategy for Rheumatoid Arthritis by Induction of Myeloid-Derived Suppressor Cells with High Suppressive PotentialShohei Nakano, Norihisa Mikami, Mai Miyawaki, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|May 6, 2022
Sivelestat's effect on Candida albicans water-soluble fraction-induced vasculitisYuya Yoshida, Rie Banno-Terada, Masashi Takada, et al.
Pageof 3